Tag: 30-month stay

30-Month Stay: How Patent Litigation Delays Generic Drug Approval

30-Month Stay: How Patent Litigation Delays Generic Drug Approval

Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation, impacting costs and market access.

View More

Search

Latest Posts

What Are Biosimilars? A Simple Guide for Patients

What Are Biosimilars? A Simple Guide for Patients

Drug-Related Headaches: How to Spot and Stop Medication Overuse Headaches

Drug-Related Headaches: How to Spot and Stop Medication Overuse Headaches

How to Address Allergies to Inactive Ingredients in Generics

How to Address Allergies to Inactive Ingredients in Generics

TRIPS Agreement and Generic Medicine Access: How Patent Rules Limit Global Health Equity

TRIPS Agreement and Generic Medicine Access: How Patent Rules Limit Global Health Equity

Rare Adverse Events with Generics: When and How to Report Side Effects

Rare Adverse Events with Generics: When and How to Report Side Effects

Categories

Tags